Medicare Cost Report Filing Extension for Hospitals Reporting Allogeneic Hematopoietic Stem Cell Transplant Acquisition Costs for Cost Reimbursement

The Medicare cost report due date has been extended for hospitals seeking cost reimbursement for allogeneic hematopoietic stem cell transplant (HSCT) acquisition costs for cost reporting periods beginning on or after October 1, 2020. Medicare Administrative Contractors (MACs) must approve a cost report submission extension for a hospital seeking cost reimbursement for allogeneic HSCT acquisition costs when the hospital PS&R data indicate that the hospital billed revenue code 815 and Medicare paid DRG 014.

A hospital seeking cost reimbursement for allogeneic HSCT acquisition costs must submit their Medicare cost report to their MAC no later than 30 days after CMS approves the cost reporting software updated to report allogeneic HSCT acquisition costs and contractors must final settle the cost report using the latest available software updated to compute payment of allogeneic HSCT acquisition costs at reasonable cost.

A hospital may submit their Medicare cost report prior to the availability of updated software to report allogeneic HSCT acquisition costs and subsequently submit an amended cost report using the updated software.

To request an extension to file the Medicare Cost Report, please submit a written request to include the following information:

• Facility name
• Facility number
• Fiscal year end
• Reason for the extension request

The request should be emailed to STAR@palmettogba.com.